GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » Float Percentage Of Total Shares Outstanding

China Medical System Holdings (HKSE:00867) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, China Medical System Holdings's float shares is 0.00 Mil. China Medical System Holdings's total shares outstanding is 2,439.53 Mil. China Medical System Holdings's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, China Medical System Holdings's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, China Medical System Holdings's Institutional Ownership is 22.42%.


China Medical System Holdings Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

China Medical System Holdings's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/2,439.53
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings (HKSE:00867) Business Description

Industry
Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.
Executives
Treasure Sea Limited 2101 Beneficial owner
Lam Kong 2201 Interest of corporation controlled by you

China Medical System Holdings (HKSE:00867) Headlines

No Headlines